BioSpace News Archive

vTv Therapeutics has provided worldwide rights for its novel clinical-stage Nrf2 activator compound, HPP971, to newly formed Anteris Bio.

Many drug makers are investing in new science and hope to develop new therapeutics that address autoimmune disease. BioSpace has captured some key efforts.

Sensorion announces that Sonova Holding AG, a leading provider of hearing solutions, will acquire a 3.7% ownership stake in Sensorion by way of subscription to a reserved share capital increase for total gross proceeds of €5 million.

Within the global healthcare ecosystem, concerns pertaining to the use of radiation and diagnostic imaging tests have led to a considerable rise in the research and development expenditure.

Fluconazole is an antifungal medication that belongs to a class of drugs called azole antifungals, which are used for various yeast and fungal infections such as oropharyngeal candidiasis, vaginal candidiasis, esophageal candidiasis, fungal meningitis and other candida infections including urinary tract infection and peritonitis.

Evolving consumer trends, in terms of diet and consumption of various nutritional products, are one of the major factors expected to have a strong influence on the overall growth of the global clinical nutrition products market in the upcoming years.

Audiological devices are amplifiers that are utilized as a part of the conclusion and treatment of hearing misfortune and adjust issue.

Burning Rock Biotech Limited announced that it entered into an exclusive licensing agreement with Oncocyte Corporation to bring DetermaRx™, a risk stratification test for early stage lung cancer patients, to China.

Cyxone, a clinical stage biotech company developing first-in-class drugs for diseases of the immune system, announced that the company has filed an Investigational New Drug application with the US Food and Drug Administration pertaining to its drug candidate Rabeximod.

Alume Biosciences, Inc. announced that it has been awarded a $2.5M Phase II Small Business Innovation Research grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health.